Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods
Research output: Contribution to journal › Article › peer-review
Standard Standard
Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods. / Bourke, Shiobhan M.; Plumpton, Catrin; Hughes, Dyfrig.
In: Value in Health, Vol. 21, No. 5, 09.05.2018, p. 538-546.
In: Value in Health, Vol. 21, No. 5, 09.05.2018, p. 538-546.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Bourke, SM, Plumpton, C & Hughes, D 2018, 'Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods', Value in Health, vol. 21, no. 5, pp. 538-546.
APA
Bourke, S. M., Plumpton, C., & Hughes, D. (2018). Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods. Value in Health, 21(5), 538-546.
CBE
Bourke SM, Plumpton C, Hughes D. 2018. Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods. Value in Health. 21(5):538-546.
MLA
Bourke, Shiobhan M., Catrin Plumpton, and Dyfrig Hughes. "Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods". Value in Health. 2018, 21(5). 538-546.
VancouverVancouver
Bourke SM, Plumpton C, Hughes D. Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods. Value in Health. 2018 May 9;21(5):538-546.
Author
RIS
TY - JOUR
T1 - Societal preferences for funding orphan drugs in the United Kingdom
T2 - An application of person trade off and discrete choice experiment methods
AU - Bourke, Shiobhan M.
AU - Plumpton, Catrin
AU - Hughes, Dyfrig
PY - 2018/5/9
Y1 - 2018/5/9
KW - Orphan drugs
KW - Person trade-off
KW - Discrete choice experiment
KW - Rare disease
KW - Resource allocation
KW - Societal preferences
M3 - Article
VL - 21
SP - 538
EP - 546
JO - Value in Health
JF - Value in Health
SN - 1524-4733
IS - 5
ER -